Sublingual Cyclobenzaprine Approved in the United States for Adult Fibromyalgia Treatment
Sublingual cyclobenzaprine has received US approval for adult fibromyalgia after phase III trials demonstrated pain reduction and improved sleep quality.
Sublingual cyclobenzaprine has received US approval for adult fibromyalgia after phase III trials demonstrated pain reduction and improved sleep quality.
A cross-sectional survey of 1,150 Indian dental providers revealed a 12.4 percentage point gap between geriatric prescribing knowledge and self-reported ...
A scoping review of studies published from 1995 to 2025 finds that autism-adapted psychosocial therapies show the most consistent signals ...
A scoping review of 30 studies found that coordinated counselling, medication, electronic health record support and financial measures can improve ...
A new conceptual analysis argues that prolonged multiprofessional pharmacotherapy in chronic diseases has become an organizationally complex process in which ...
A Bulgarian study combining systematic review with real-world analysis reveals that drug-related problems in geriatric patients with rare diseases are ...
A meta-analysis of 37 phase 3 trials involving more than 50,000 adults finds that weight loss explains about 76 percent ...
In a Journal of Clinical Sleep Medicine reply, researchers Ahn and Malhotra concede that central hypopnea classification lacks validated thresholds ...
Video analysis of 29 NHS memory clinic consultations shows doctors inconsistently frame the benefits and side effects of dementia medications, ...
In the vast landscape of substance use disorders, the emergence of amphetamine-type stimulants has become a pressing concern among healthcare ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.